Search

Author/Creator Fasslrinner, Frederick

1. Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial. Issue 4 (April 2018)

Authors:
Fasslrinner, Frederick; Schetelig, Johannes; Burchert, Andreas; Kramer, Michael; Trenschel, Rudolf; Hegenbart, Ute; Stadler, Michael; Schäfer-Eckart, Kerstin; Bätzel, Michael; Eich, Hans; Stuschke, Martin; Engenhart-Cabillic, Rita; Krause, Mechthild; Dreger, Peter; Neubauer, Andreas; Ehninger, Ge...
Journal:
Lancet
Issue:
Volume 5:Issue 4(2018)
Page Start:
e161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Midostaurin abrogates CD33‐directed UniCAR and CD33‐CD3 bispecific antibody therapy in acute myeloid leukaemia. (23rd May 2019)

Authors:
Fasslrinner, Frederick; Arndt, Claudia; Koristka, Stefanie; Feldmann, Anja; Altmann, Heidi; von Bonin, Malte; Schmitz, Marc; Bornhäuser, Martin; Bachmann, Michael
Journal:
British journal of haematology
Issue:
Volume 186:Number 5(2019)
Page Start:
735
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells. (1st January 2020)

Authors:
Arndt, Claudia; Loureiro, Liliana R.; Feldmann, Anja; Jureczek, Justyna; Bergmann, Ralf; Máthé, Domokos; Hegedüs, Nikolett; Berndt, Nicole; Koristka, Stefanie; Mitwasi, Nicola; Fasslrinner, Frederick; Lamprecht, Chris; Kegler, Alexandra; Hoffmann, Anja; Bartsch, Tabea; Köseer, Ayşe Sedef; Egan, G...
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗